No Data
Express News | PMV Pharmaceuticals Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing
Oppenheimer Upgrades PMV Pharmaceuticals(PMVP.US) to Buy Rating, Announces Target Price $6
PMV Pharmaceuticals Upgraded to Outperform From Perform at Oppenheimer
TD Cowen Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating
Optimistic Buy Rating for PMV Pharmaceuticals Driven by Strategic Clinical Trials and Strong Financial Position
Express News | PMV Pharmaceuticals: Cash, Cash Equivalents, & Marketable Securities of $197.9 Mln as Sept 30, Providing Expected Cash Runway to End of 2026
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
